These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37029427)

  • 1. Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity.
    Jamialahmadi T; Bo S; Abbasifard M; Sathyapalan T; Jangjoo A; Moallem SA; Almahmeed W; Ashari S; Johnston TP; Sahebkar A
    J Health Popul Nutr; 2023 Apr; 42(1):30. PubMed ID: 37029427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
    Tavaglione F; De Vincentis A; Bruni V; Gallo IF; Carotti S; Tuccinardi D; Spagnolo G; Ciociola E; Mancina RM; Jamialahmadi O; D'Alessio R; Bottazzi B; Manfrini S; Picardi A; Perrone G; Pozzilli P; Caricato M; Vespasiani-Gentilucci U; Romeo S
    Liver Int; 2022 Feb; 42(2):374-383. PubMed ID: 34890093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
    Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.
    Naveau S; Lamouri K; Pourcher G; Njiké-Nakseu M; Ferretti S; Courie R; Tranchart H; Ghinoiu M; Balian A; Prévot S; Perlemuter G; Dagher I
    Obes Surg; 2014 Oct; 24(10):1693-701. PubMed ID: 24841950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity.
    da Silva RG; de Miranda MLQ; de Araújo Caldeira Brant PE; Schulz PO; de Fátima Araujo Nascimento M; Schmillevitch J; Vieira A; de Freitas WR; Szutan LA
    Arch Endocrinol Metab; 2021 Nov; 65(6):730-738. PubMed ID: 34762779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Evaluation of Acoustic Radiation Force Impulse Shear Wave Imaging to Detect Hepatic Fibrosis in Morbidly Obese Patients Before Bariatric Surgery.
    Praveenraj P; Gomes RM; Basuraju S; Kumar S; Senthilnathan P; Parathasarathi R; Rajapandian S; Palanivelu C
    J Laparoendosc Adv Surg Tech A; 2016 Mar; 26(3):192-5. PubMed ID: 26895403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography.
    de Barros F; Setúbal S; Martinho JM; Leite NC; Guaraná T; Monteiro ABS; Villela-Nogueira CA
    Obes Surg; 2016 Sep; 26(9):2089-2097. PubMed ID: 26803754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature.
    Puthenpura MM; Patel V; Fam J; Katz L; Tichansky DS; Myers S
    Obes Surg; 2020 Dec; 30(12):5108-5116. PubMed ID: 32981002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
    Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort.
    Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M
    Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.